Thymic lymphomas arising in Msh2 deficient mice display a large increase in mutation frequency and an altered mutational spectrum

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 500, Issue 1-2, 2002, Pages 67-74

  Zhang, Shulin ^a   Lloyd, Ruth ^a   Bowden, Gregory ^a   Glickman, Barry W ^a   De Boer, Johan G ^a  

^a UNIVERSITY OF VICTORIA   (Canada)

Author keywords

lacI; Msh2; Mutator genes; Thymic lymphoma

Indexed keywords

PROTEIN MSH2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DNA REPLICATION; FRAMESHIFT MUTATION; GENE SEQUENCE; MALE; MISMATCH REPAIR; MOUSE; MUTATION RATE; MUTATIONAL ANALYSIS; MUTATOR GENE; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; PROTEIN DEFICIENCY; THYMUS LYMPHOMA;

ANIMALIA;

EID: 0037139195     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(01)00297-4     Document Type: Article

References (35)

1. Foundations in cancer research. Chromosomes and cancer: The evolution of an idea
2. Genetic alterations during colorectal-tumor development
3. The mutation rate and cancer
4. Mutator phenotype may be required for multistage carcinogenesis
5. Errors in DNA replication as a basis of malignant changes
6. Mismatch repair and genetic stability in human cells
7. Multiple mutations in human cancers
8. MutS homologs in mammalian cells
9. Spontaneous intestinal carcinomas and skin neoplasms in Msh2-deficient mice
10. The use of shuttle vectors for mutation analysis in transgenic mice and rats
11. A novel lacI transgenic mutation-detection system and its application to establish baseline mutation frequencies in the scid mouse
12. p53 wild-type and p53 nullizygous Big Blue transgenic mice have similar frequencies and patterns of observed mutation in liver, spleen and brain
13. A 3 mT 60 Hz magnetic field is neither mutagenic nor co-mutagenic in the presence of menadione and MNU in a transgenic rat cell line
14. Intralaboratory optimization and standardization of mutant screening conditions used for a lambda/lacI transgenic mouse mutagenesis assay (I)
15. An efficient laboratory protocol for the sequencing of large numbers of lacI mutants recovered from Big Blue transgenic animals
16. Database and software for the analysis of mutations at the lacI gene in both transgenic rodents and bacteria
17. Statistical test for the comparison of samples from mutational spectra
18. Tumors of DNA mismatch repair-deficient hosts exhibit dramatic increases in genomic instability
19. Spontaneous mutation of the lacI transgene in rodents: Absence of species, strain, and insertion-site influence
20. DNA mismatch repair and genetic instability
21. Microsatellite instability, mismatch repair deficiency, and genetic defects in human cancer cell lines
22. Origin of multiple mutations in human cancers
23. Transgenic models for detection of mutations in tumors and normal tissues of rodents
24. Single nucleotide instability without microsatellite instability in rat mammary carcinomas
25. Preferential induction of guanine deletion at 5′-GGGA-3′ in rat mammary glands by 2-amino- 1-methyl-6-phenylimidazo[4,5-b]pyridine
26. Increased mutation frequency and altered spectrum in one of four thymic lymphomas derived from tumor prone p53/Big Blue double transgenic mice
27. Mechanisms of mutagenesis in the Escherichia coli mutator mutD5: Role of DNA mismatch repair
28. DNA damage-induced mutation: Tolerance via translesion synthesis
29. Cancer-susceptibility genes. Gatekeepers and caretakers
30. Genetic instability induced by the tumor microenvironment
31. The clonal evolution of tumor cell populations
32. Mutations associated with microsatellite unstable colorectal carcinomas exhibit widespread intratumoral heterogeneity
33. Tumors arising in DNA mismatch repair-deficient mice show a wide variation in mutation frequency as assessed by a transgenic reporter gene
34. Conditional mutator phenotypes in hMSH2-deficient tumor cell lines
35. The origin of point mutations in human tumor cells